# Advanced Flower Capital Inc.: overview AFCG · Nasdaq · CIK 1822523 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/afcg.md) · [Financials](/companies/afcg/financials.md) · [Filings](/companies/afcg/filings.md) · [Insiders](/companies/afcg/insiders.md) Latest reported revenue: [$5.2m](/filings/0001628280-26-014392.md) for Q4 FY2025, three months to 2025-12-31, from the 10-K filed Mar 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-014392). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [8,882](/filings/0001628280-25-051319.md) | [7,637 d](/filings/0001628280-26-014392.md) | [6,643](/filings/0001628280-26-031692.md) | [6,203](/filings/0001628280-26-056471.md) | [6,531](/filings/0001628280-25-051319.md) | [5,186 d](/filings/0001628280-26-014392.md) | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [15.6%](/filings/0001628280-25-051319.md) | [(13.0%) d](/filings/0001628280-26-014392.md) | [61.2%](/filings/0001628280-26-031692.md) | [(212.2%)](/filings/0001628280-26-056471.md) | [(191.3%)](/filings/0001628280-25-051319.md) | [17.6% d](/filings/0001628280-26-014392.md) | not reported | not reported | | Diluted EPS | $ per share | [0.06](/filings/0001628280-25-051319.md) | not reported | [0.18](/filings/0001628280-26-031692.md) | [(0.60)](/filings/0001628280-26-056471.md) | [(0.57)](/filings/0001628280-25-051319.md) | not reported | [0.49](/filings/0001628280-26-031692.md) | [0.23](/filings/0001628280-26-056471.md) | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | [74.7](/filings/0001822523-24-000014.md) | [63.9](/filings/0001822523-25-000003.md) | [45.7](/filings/0001628280-26-014392.md) | [24.6](/filings/0001628280-26-014392.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | [48.1%](/filings/0001822523-24-000014.md) | [32.8%](/filings/0001822523-24-000014.md) | [36.8%](/filings/0001628280-26-014392.md) | [(84.2%)](/filings/0001628280-26-014392.md) | | Diluted EPS | $ per share | [1.52](/filings/0001822523-23-000006.md) | [1.79](/filings/0001822523-24-000014.md) | [1.02](/filings/0001822523-25-000003.md) | [0.78](/filings/0001628280-26-014392.md) | [(0.95)](/filings/0001628280-26-014392.md) | | Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Net income: us-gaap:ProfitLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/afcg/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [CDC Financial, Inc.](/funds/2077836.md) | 2026-06-30 | $5.6m | 1,797,359 | | Added +324,181 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $1.3m | 418,479 | | Added +189,412 | | [MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.](/funds/1705339.md) | 2026-06-30 | $683.2k | 220,387 | | Added +27,841 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $619.7k | 199,911 | | Added +55,441 | | [Squarepoint Ops LLC](/funds/1642575.md) | 2026-06-30 | $594.6k | 191,798 | | Added +130,652 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $558.3k | 180,100 | Put | Added +50,500 | | [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $537.0k | 173,233 | | New +173,233 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $376.8k | 121,543 | | Added +399 | | [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $361.1k | 116,471 | | Added +18,847 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $354.7k | 114,407 | | Reduced −86,443 | ## Recent filings [All 350 filings](/companies/afcg/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-29 | 16:15 ET | [8-K](/filings/0001628280-26-063811.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-26-063811 | | 2026-09-15 | 17:16 ET | [8-K](/filings/0001628280-26-062097.md) | 7.01 Regulation FD disclosure | 0001628280-26-062097 | | 2026-09-15 | 17:12 ET | [SCHEDULE 13D/A](/filings/0001829126-26-010121.md) | Ownership report, active investor, amended | 0001829126-26-010121 | | 2026-08-26 | 16:37 ET | [8-K](/filings/0001628280-26-059110.md) | 7.01 Regulation FD disclosure | 0001628280-26-059110 | | 2026-08-26 | 16:25 ET | [SCHEDULE 13D/A](/filings/0001829126-26-009359.md) | Ownership report, active investor, amended | 0001829126-26-009359 | | 2026-08-13 | 07:35 ET | [8-K](/filings/0001628280-26-056475.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-056475 | | 2026-08-13 | 07:30 ET | [10-Q](/filings/0001628280-26-056471.md) | Quarterly report, period 2026-06-30 | 0001628280-26-056471 | | 2026-06-30 | 16:30 ET | [8-K](/filings/0001628280-26-046244.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-26-046244 | | 2026-06-18 | 16:19 ET | [8-K](/filings/0001628280-26-044326.md) | 7.01 Regulation FD disclosure | 0001628280-26-044326 | | 2026-06-18 | 16:10 ET | [SCHEDULE 13D/A](/filings/0001829126-26-006681.md) | Ownership report, active investor, amended | 0001829126-26-006681 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-014392.md), filed Mar 4, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1822523 - Tickers: AFCG - Exchange: Nasdaq - SIC code: not reported - State of incorporation: MD - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.